New Collaboration Will Support Platform Evaluation, Evidence Synthesis, and Strategic Communications to Help Strengthen VitalFriend’s Innovation Roadmap
HITLAB and ENB Therapeutics Partner to Transform Immunotherapy-Resistant Cancers into Clinical Victories